Cyclosporin A (CsA) is a promising therapeutic drug for myocardial ischemia reperfusion injury (MI/RI) because of its definite inhibition to the opening of mitochondrial permeability transition pore (mPTP). Ho...
from Most Recent Articles: Journal of Nanobiotechnology http://bit.ly/2UeSKAL
via IFTTT
No comments:
Post a Comment